VBI Vaccines Inc (NASDAQ:VBIV)
| 0.7262 Delayed Data As of Sep 23 |  -0.0065 / -0.89%Today’s Change | 0.64 Today|||52-Week Range 3.49 | -68.97% Year-to-Date |
Latest VBIV News | Press Releases
No recent news for VBI Vaccines Inc.
Today’s Trading
| Previous close | 0.73 |
| Today’s open | 0.74 |
| Day’s range | 0.71 - 0.74 |
| Volume | 26,150 |
| Average volume (3 months) | 1,965,790 |
| Market cap | $210.5M |
Data as of 4:00pm ET, 09/23/2022
Growth & Valuation
| Earnings growth (last year) | -29.18% |
| Earnings growth (this year) | -37.04% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -40.53% |
| P/E ratio | NM |
| Price/Sales | 945.45 |
| Price/Book | 1.46 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AUTLAutolus Therapeutics... | -0.11 | -5.16% |
| RIGLRigel Pharmaceutical... | -0.05 | -4.74% |
| ADAPAdaptimmune Therapeu... | -0.17 | -12.78% |
| XOMAXOMA Corp | +1.05 | +6.49% |
Data as of 4:00pm ET, 09/23/2022
Financials
| Next reporting date | November 7, 2022 |
| EPS forecast (this quarter) | -$0.08 |
| Annual revenue (last year) | $631.0K |
| Annual profit (last year) | -$69.8M |
| Net profit margin | -11,054.36% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cambridge, Massachusetts |
Forecasts
